Quarterly report [Sections 13 or 15(d)]

Stockholders??? Equity (Details Narrative)

v3.25.4
Stockholders’ Equity (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
Dec. 23, 2024
Nov. 13, 2023
Sep. 28, 2022
Dec. 31, 2024
Dec. 31, 2024
Dec. 31, 2025
Dec. 31, 2024
Jun. 30, 2025
Apr. 04, 2025
Subsidiary, Sale of Stock [Line Items]                  
Common stock, shares authorized           75,000,000   75,000,000  
Proceeds from common stock           $ 15,000,000    
Securities Purchase Agreement [Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Shares issued 15,151,514                
Share price $ 0.99                
Common Stock [Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Shares issued         15,151,514        
Financing fees         $ 37,597        
Common Stock [Member] | Loan and Sercurity Agreement [Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Shares issued   300,000              
Private Placement [Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Shares issued     2,264,650            
Stock issued during period, value, new issues     $ 6,600,000            
Share price     $ 2.935            
Proceeds from issuance or sale of equity     $ 6,300,000            
Financing fees     $ 300,000            
Warrant exercise price per share     $ 4.215            
Proceeds from common stock $ 15,000,000.0     $ 14,900,000          
Offering expenses $ 100,000                
Minimum [Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Common stock, shares authorized                 50,000,000
Maximum [Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Common stock, shares authorized                 75,000,000